$ARNA MULTIYEAR BREAKOUT , HUGE POTENTIAL

********HUGE POTENTIAL PROFITS ON IMPENDING BREAKOUT AFTER FORMING CAP AND HANDLE , WE AWAIT A UPTAKE IN VOLUME AND A BREAK ABOVE $59 TO CONFIRM SETUP, INDICATORS ARE ALL BULLISH, LOOKS LIKE A GEM*****


AVERAGE ANALYSTS PRICE TARGET $67
AVERAGE ANALYST RECOMMENDATION BUY

COMPANY PROFILE
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.